Investors Bet $235 Million on Bringing AI to Scientific Research
Lila Sciences, which uses AI to develop novel drugs and materials, has received fresh funding led by Collective Global and Braidwell.
Scientists working in Lila Science’s labs.
Photo courtesy of Lila Sciences/Cody O'Loughlin
The latest artificial intelligence unicorn is Lila Sciences, a biotechnology company that promises to speed the rate of scientific discovery using new AI tools.
The startup announced it had raised $235 million at a roughly $1.23 billion valuation.